PACS Group, Inc.
Business Overview: PACS Group, Inc. (NYSE: PACS)
Executive Summary
PACS Group, Inc. is a Delaware corporation headquartered in Farmington, Utah, founded in 2013, that operates as a post-acute healthcare company focused on skilled nursing care. Its core growth strategy is acquiring underperforming long-term custodial skilled nursing facilities (SNFs) and converting them, over a transition period of up to three years, into higher-acuity, short-term transitional care facilities with improved clinical outcomes and occupancy.
As of year-end 2024, PACS operated 314 facilities across 17 states, serving over 30,100 patients daily and employing 45,680 people, including 26,788 clinicians, generating $4.1 billion in total 2024 revenue.
1. Core Business Model & How They Work
[ Identify & acquire underperforming SNFs ] -> [ Apply PACS operating playbook over ~3-year transition ] -> [ Convert to higher-acuity, short-term transitional care ] -> [ Improved occupancy, quality scores & reimbursement mix ]
- Decentralized operating model: each facility is run by a local administrator with operating autonomy — a deliberate structural choice meant to preserve local responsiveness and accountability rather than impose centralized clinical decision-making.
- Centralized support platform ("PACS Services"): a shared-services layer covering accounting, finance, HR, payroll, accounts receivable/payable, legal, compliance, risk management, and technology (including a third-party electronic health record system and an internally developed operational dashboard) — giving local administrators scale-level back-office support without sacrificing site-level autonomy.
- Acquisition-driven growth engine: PACS has historically executed roughly 25 acquisitions plus one de novo build per year on average, having acquired over 300 facilities to date, with facilities categorized by time-since-acquisition (Mature: 36+ months; Ramping: 18-36 months; New: under 18 months) to track the conversion pipeline.
- Adjacent expansion: beyond core SNF operations, PACS operates one independent living and 26 assisted living facilities, and has outlined early plans for "PACS Ventures" — ancillary businesses in pharmacy, lab, transportation, and imaging — though these are not yet described as operating segments.
2. Business Segments
PACS Group, Inc.
+------------------+------------------+------------------+
| | | |
v v v v
Mature Ramping New Senior Living
(138 facilities) (50 facilities) (126 facilities) (1 IL + 26 AL)
36+ months since 18-36 months <18 months since
acquisition since acquisition acquisition
Rather than formal reportable segments, PACS tracks its skilled nursing portfolio by acquisition vintage — Mature, Ramping, and New — reflecting how far each facility has progressed through its standardized conversion playbook, alongside a smaller senior living (independent/assisted living) portfolio.
3. Product Portfolio (Services Provided)
| Service | Facilities | Purpose | Why It Matters |
|---|---|---|---|
| Skilled Nursing Care | 314 facilities, 17 states | Short-term transitional and long-term custodial care | Core business; driven by converting underperforming acquisitions to higher-acuity care |
| Assisted & Independent Living | 1 IL + 26 AL facilities | Senior living services outside skilled nursing | Diversifies the portfolio modestly beyond core SNF reimbursement dynamics |
| PACS Services (shared platform) | Enterprise-wide | Centralized accounting, HR, compliance, technology | Enables scale economics while preserving local facility-level autonomy |
| PACS Ventures (planned) | Not yet operating | Pharmacy, lab, transportation, imaging ancillary services | Potential future revenue diversification tied to the existing patient base |
4. Competitive Landscape
PACS does not name specific competitors in its filing, instead describing competitive categories: local and regional skilled nursing providers, large national providers, inpatient rehabilitation facilities, long-term acute care hospitals, and home health and community-based care providers.
- Competition in skilled nursing is highly fragmented and local, with facility reputation, clinical quality (Quality Measure star ratings), occupancy, and payor-mix management driving competitive positioning more than brand recognition.
- PACS's Mature facilities report an average 4.3-star Quality Measure rating versus an industry average of 3.4, and 94% occupancy versus an industry average of 77% — concrete evidence its operating playbook outperforms typical industry benchmarks once a facility matures.
- Home health and community-based alternatives represent a longer-term competitive and substitution risk as payors and patients increasingly favor lower-cost, non-institutional care settings where clinically appropriate.
5. Strategic Strengths & Risks
Strengths
- Proven acquisition-and-turnaround playbook: the stark gap between Mature-facility performance (4.3-star rating, 94% occupancy) and industry averages (3.4 stars, 77% occupancy) suggests PACS has a genuinely repeatable method for improving underperforming facilities.
- Scale shared-services platform: PACS Services lets the company support 314 facilities with centralized back-office functions while preserving the local autonomy that may drive better clinical and occupancy outcomes.
- Diversified payor base: a mix of Medicare (33.8% of routine revenue), Medicaid (40.4%), and managed care/other reduces dependence on any single reimbursement source, though all remain subject to government policy risk.
- Growing financial scale: revenue grew from $3.1 billion in 2023 to $4.1 billion in 2024, with Adjusted EBITDA rising from $237.5 million to $279.5 million over the same period.
Risks
- Heavy reliance on government reimbursement: Medicare and Medicaid together represented roughly 74% of routine revenue in 2024, exposing PACS directly to policy, rate-setting, and regulatory changes outside its control.
- Declining net income despite revenue growth: net income fell from $112.9 million in 2023 to $55.3 million in 2024 even as revenue grew — a divergence worth scrutinizing in the full financial statements (e.g., acquisition costs, interest expense, or integration costs).
- Execution-dependent growth model: continued growth depends on sourcing, acquiring, and successfully converting underperforming facilities at a steady pace (roughly 25/year historically) — a model that could slow if attractive acquisition targets become scarcer or more expensive.
- Highly regulated, labor-intensive industry: skilled nursing faces continuous regulatory, staffing, and quality-of-care scrutiny, and 5,718 employees are unionized, adding labor-relations complexity alongside already-tight healthcare labor markets.
6. Financial Overview
| Metric | PACS Group Profile (FY2024) | Strategic Context |
|---|---|---|
| Total Revenue | $4.1 billion (up from $3.1B in 2023) | Strong top-line growth driven by acquisitions and facility conversions |
| Net Income | $55.3 million (down from $112.9M in 2023) | Notable decline despite revenue growth - warrants scrutiny |
| Adjusted EBITDA (non-GAAP) | $279.5 million (up from $237.5M in 2023) | Core operating profitability improving even as net income fell |
| Facilities / Daily Patients | 314 facilities / 30,100+ patients daily | Broad multi-state operating footprint |
| Mature Facility Occupancy | 94% vs. 77% industry average | Evidence of the operating playbook's effectiveness once facilities mature |
7. Summary Conclusion
PACS Group has built a scaled, repeatable playbook for acquiring underperforming skilled nursing facilities and converting them into higher-acuity, better-performing operations — a strategy evidenced by its Mature facilities' outsized occupancy and quality-rating advantages over industry averages. The business remains fundamentally dependent on continued acquisition execution and on government reimbursement policy (Medicare and Medicaid together are roughly three-quarters of routine revenue), and the divergence between rising revenue/EBITDA and falling net income in 2024 is a detail worth watching closely as the company scales further.